Drug intelligence / Profile preview

Rhinase Soothing Nasal Gel

Development stage: Unknown
Lead developer: Profounda
Modality: Small Molecules
Administration: Intranasal

Overview

Rhinase Soothing Nasal Gel is an over-the-counter, steroid-free nasal moisturizer developed by Profounda Inc. It is specifically formulated with a dual-salt composition (sodium chloride and potassium chloride) and dual wetting agents at a pH of 6.2 to match the physiological environment of the nose. Administered intranasally, the gel is designed to relieve nasal dryness and irritation caused by factors such as low humidity, allergies, chronic sinusitis, CPAP/BiPAP use, and oxygen therapy. It works by providing moisture to dissolve and soften thick or crusty mucus without the use of aloe, dyes, or fragrances, making it suitable for both adults and children.

Brand names: Rhinase Soothing Nasal Gel
Other names: Rhinase Nasal Gel

Beyond the preview

Go deeper on Rhinase Soothing Nasal Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhinase Soothing Nasal Gel.

Explore the full profile